Advancing early-stage discoveries
to transform healthcare

Our Mission

Leveraging a broad innovation network, our venture team identifies transformational healthcare ideas at leading research labs and medical centers, then works with scientific founders to quickly hit development milestones.

Learn More

Cultivating Innovation and Propelling Development

We’re not your typical healthcare VC firm. Through our strategic investments and partnerships, ShangPharma Innovation is focused on filling the critical investment gap that exists for earliest-stage therapeutic breakthroughs.

Learn More

What We Provide

Portfolio

Contact

Latest News

ShangPharma Innovation portfolio company Tilos Therapeutics acquired for up to $773 Million by Merck

June 12, 2019/in Media /by shawn

Venture capital firm ShangPharma Innovation is growing its life science incubator on the West Coast as it looks to help early-stage biomedical work get off the ground with more lab space.

Latest News

ShangPharma Innovation portfolio company Tilos Therapeutics acquired for up to $773 Million by Merck

June 12, 2019/in Media /by shawn

Venture capital firm ShangPharma Innovation is growing its life science incubator on the West Coast as it looks to help early-stage biomedical work get off the ground with more lab space.

Advancing early-stage discoveries to transform healthcare

Advancing early-stage discoveries to transform healthcare

Our Mission

Cultivating Innovation and Propelling Development

What We Provide

Portfolio

Contact

Latest News

Latest News

Advancing early-stage discoveries
to transform healthcare

Advancing early-stage discoveries
to transform healthcare